25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Island Pharmaceuticals Ltd
Buy, Hold or Sell?

Let's analyze Island Pharmaceuticals Ltd together

I guess you are interested in Island Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Island Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.

1. Quick Overview

1.1. Quick analysis of Island Pharmaceuticals Ltd (30 sec.)










1.2. What can you expect buying and holding a share of Island Pharmaceuticals Ltd? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.01
Expected worth in 1 year
A$0.00
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
A$-0.01
Return On Investment
-4.4%

For what price can you sell your share?

Current Price per Share
A$0.13
Expected price per share
A$0.1 - A$0.155
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Island Pharmaceuticals Ltd (5 min.)




Live pricePrice per Share (EOD)
A$0.13
Intrinsic Value Per Share
A$-0.25 - A$-0.30
Total Value Per Share
A$-0.24 - A$-0.29

2.2. Growth of Island Pharmaceuticals Ltd (5 min.)




Is Island Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$965k$1.1m-$169.3k-17.5%

How much money is Island Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$1.7m-$21.5k-1.2%
Net Profit Margin-228.9%-25,580.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Island Pharmaceuticals Ltd (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#771 / 925

Most Revenue
#517 / 925

Most Profit
#277 / 925

Most Efficient
#532 / 925
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Island Pharmaceuticals Ltd?

Welcome investor! Island Pharmaceuticals Ltd's management wants to use your money to grow the business. In return you get a share of Island Pharmaceuticals Ltd.

First you should know what it really means to hold a share of Island Pharmaceuticals Ltd. And how you can make/lose money.

Speculation

The Price per Share of Island Pharmaceuticals Ltd is A$0.13. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Island Pharmaceuticals Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Island Pharmaceuticals Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.01. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Island Pharmaceuticals Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.01-7.6%-0.01-7.6%-0.01-7.5%-0.01-5.5%-0.01-5.5%
Usd Book Value Change Per Share0.00-0.7%0.00-0.7%-0.01-6.7%0.000.8%0.000.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-0.7%0.00-0.7%-0.01-6.7%0.000.8%0.000.8%
Usd Price Per Share0.06-0.06-0.12-0.07-0.07-
Price to Earnings Ratio-6.12--6.12--12.06--7.25--7.25-
Price-to-Total Gains Ratio-65.79--65.79--13.48--33.96--33.96-
Price to Book Ratio11.54-11.54-19.13-8.31-8.31-
Price-to-Total Gains Ratio-65.79--65.79--13.48--33.96--33.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.082602
Number of shares12106
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (12106 shares)-11.1112.66
Gains per Year (12106 shares)-44.4350.64
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-44-5405141
20-89-98010192
30-133-1420152143
40-178-1860203194
50-222-2300253245
60-267-2740304296
70-311-3180354347
80-355-3620405398
90-400-4060456449
100-444-4500506500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.05.00.00.0%0.05.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.05.00.0%0.00.05.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%1.04.00.020.0%1.04.00.020.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Island Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.0010%-0.014+850%0.002-188%0.002-188%
Book Value Per Share--0.0080.0080%0.010-15%0.015-46%0.015-46%
Current Ratio--2.4532.4530%7.767-68%9.340-74%9.340-74%
Debt To Asset Ratio--0.4080.4080%0.129+217%8.068-95%8.068-95%
Debt To Equity Ratio--0.6880.6880%0.148+366%0.202+242%0.202+242%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--18148903.00018148903.0000%35879867.000-49%35100274.667-48%35100274.667-48%
Eps---0.016-0.0160%-0.015-1%-0.011-27%-0.011-27%
Ev To Ebitda Ratio---6.440-6.4400%-12.338+92%-12.344+92%-12.344+92%
Ev To Sales Ratio--14.50114.5010%3242.645-100%infnan%infnan%
Free Cash Flow Per Share---0.017-0.0170%-0.015-14%-0.009-45%-0.009-45%
Free Cash Flow To Equity Per Share---0.002-0.0020%-0.016+661%0.009-123%0.009-123%
Gross Profit Margin--1.1221.1220%1.058+6%1.036+8%1.036+8%
Intrinsic Value_10Y_max---0.300--------
Intrinsic Value_10Y_min---0.252--------
Intrinsic Value_1Y_max---0.017--------
Intrinsic Value_1Y_min---0.017--------
Intrinsic Value_3Y_max---0.062--------
Intrinsic Value_3Y_min---0.059--------
Intrinsic Value_5Y_max---0.118--------
Intrinsic Value_5Y_min---0.108--------
Market Cap23994100.000+27%17534150.00017534150.0000%34145450.000-49%19748990.000-11%19748990.000-11%
Net Profit Margin---2.289-2.2890%-255.802+11077%-51.618+2155%-51.618+2155%
Operating Margin---2.296-2.2960%-524.645+22749%-105.388+4490%-105.388+4490%
Operating Ratio--5.1125.1120%262.823-98%53.587-90%53.587-90%
Pb Ratio15.798+27%11.54411.5440%19.125-40%8.314+39%8.314+39%
Pe Ratio-8.377-37%-6.122-6.1220%-12.064+97%-7.248+18%-7.248+18%
Price Per Share0.130+27%0.0950.0950%0.185-49%0.107-11%0.107-11%
Price To Free Cash Flow Ratio-7.581-37%-5.540-5.5400%-12.606+128%-8.642+56%-8.642+56%
Price To Total Gains Ratio-90.025-37%-65.788-65.7880%-13.481-80%-33.962-48%-33.962-48%
Quick Ratio--2.4402.4400%7.639-68%9.183-73%9.183-73%
Return On Assets---1.117-1.1170%-1.381+24%-8.411+653%-8.411+653%
Return On Equity---1.886-1.8860%-1.585-16%-0.881-53%-0.881-53%
Total Gains Per Share---0.001-0.0010%-0.014+850%0.002-188%0.002-188%
Usd Book Value--965075.384965075.3840%1134426.004-15%1781761.485-46%1781761.485-46%
Usd Book Value Change Per Share---0.001-0.0010%-0.009+850%0.001-188%0.001-188%
Usd Book Value Per Share--0.0050.0050%0.006-15%0.010-46%0.010-46%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--11531812.96611531812.9660%22798067.492-49%22302714.523-48%22302714.523-48%
Usd Eps---0.010-0.0100%-0.010-1%-0.007-27%-0.007-27%
Usd Free Cash Flow---2011006.053-2011006.0530%-1721146.739-14%-1104273.860-45%-1104273.860-45%
Usd Free Cash Flow Per Share---0.011-0.0110%-0.009-14%-0.006-45%-0.006-45%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.010+661%0.006-123%0.006-123%
Usd Market Cap15245851.140+27%11141198.91011141198.9100%21696018.930-49%12548508.246-11%12548508.246-11%
Usd Price Per Share0.083+27%0.0600.0600%0.118-49%0.068-11%0.068-11%
Usd Profit---1819987.657-1819987.6570%-1798467.295-1%-1325325.834-27%-1325325.834-27%
Usd Revenue--795250.755795250.7550%7030.701+11211%160456.291+396%160456.291+396%
Usd Total Gains Per Share---0.001-0.0010%-0.009+850%0.001-188%0.001-188%
 EOD+5 -3MRQTTM+0 -0YOY+15 -235Y+9 -2810Y+9 -28

3.3 Fundamental Score

Let's check the fundamental score of Island Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.377
Price to Book Ratio (EOD)Between0-115.798
Net Profit Margin (MRQ)Greater than0-2.289
Operating Margin (MRQ)Greater than0-2.296
Quick Ratio (MRQ)Greater than12.440
Current Ratio (MRQ)Greater than12.453
Debt to Asset Ratio (MRQ)Less than10.408
Debt to Equity Ratio (MRQ)Less than10.688
Return on Equity (MRQ)Greater than0.15-1.886
Return on Assets (MRQ)Greater than0.05-1.117
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.130
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About Island Pharmaceuticals Ltd

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a collaboration agreement with Monash University and National Cancer Institute IND. It also has a cooperative research and development agreement with the U.S. Army, Island in preparation for its Phase 2a/b clinical study for ISLA-101. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.

Fundamental data was last updated by Penke on 2025-02-17 13:07:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Island Pharmaceuticals Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -228.9% means that $-2.29 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is -228.9%. The company is making a huge loss. -2
  • The TTM is -228.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-228.9%TTM-228.9%0.0%
TTM-228.9%YOY-25,580.2%+25,351.3%
TTM-228.9%5Y-5,161.8%+4,933.0%
5Y-5,161.8%10Y-5,161.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-228.9%-100.3%-128.6%
TTM-228.9%-211.5%-17.4%
YOY-25,580.2%-213.8%-25,366.4%
5Y-5,161.8%-346.2%-4,815.6%
10Y-5,161.8%-489.2%-4,672.6%
4.3.1.2. Return on Assets

Shows how efficient Island Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -111.7% Return on Assets means that Island Pharmaceuticals Ltd generated $-1.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Island Pharmaceuticals Ltd:

  • The MRQ is -111.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -111.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-111.7%TTM-111.7%0.0%
TTM-111.7%YOY-138.1%+26.4%
TTM-111.7%5Y-841.1%+729.4%
5Y-841.1%10Y-841.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-111.7%-12.0%-99.7%
TTM-111.7%-12.1%-99.6%
YOY-138.1%-11.4%-126.7%
5Y-841.1%-12.8%-828.3%
10Y-841.1%-14.6%-826.5%
4.3.1.3. Return on Equity

Shows how efficient Island Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • -188.6% Return on Equity means Island Pharmaceuticals Ltd generated $-1.89 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Island Pharmaceuticals Ltd:

  • The MRQ is -188.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -188.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-188.6%TTM-188.6%0.0%
TTM-188.6%YOY-158.5%-30.0%
TTM-188.6%5Y-88.1%-100.4%
5Y-88.1%10Y-88.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-188.6%-15.4%-173.2%
TTM-188.6%-16.2%-172.4%
YOY-158.5%-14.7%-143.8%
5Y-88.1%-18.6%-69.5%
10Y-88.1%-19.5%-68.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Island Pharmaceuticals Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Island Pharmaceuticals Ltd is operating .

  • Measures how much profit Island Pharmaceuticals Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • An Operating Margin of -229.6% means the company generated $-2.30  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Island Pharmaceuticals Ltd:

  • The MRQ is -229.6%. The company is operating very inefficient. -2
  • The TTM is -229.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-229.6%TTM-229.6%0.0%
TTM-229.6%YOY-52,464.5%+52,234.9%
TTM-229.6%5Y-10,538.8%+10,309.2%
5Y-10,538.8%10Y-10,538.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-229.6%-201.5%-28.1%
TTM-229.6%-313.4%+83.8%
YOY-52,464.5%-215.2%-52,249.3%
5Y-10,538.8%-371.8%-10,167.0%
10Y-10,538.8%-492.1%-10,046.7%
4.3.2.2. Operating Ratio

Measures how efficient Island Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.11 means that the operating costs are $5.11 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 5.112. The company is inefficient in keeping operating costs low. -1
  • The TTM is 5.112. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.112TTM5.1120.000
TTM5.112YOY262.823-257.711
TTM5.1125Y53.587-48.475
5Y53.58710Y53.5870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1122.139+2.973
TTM5.1123.198+1.914
YOY262.8233.358+259.465
5Y53.5874.842+48.745
10Y53.5876.500+47.087
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Island Pharmaceuticals Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.45 means the company has $2.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 2.453. The company is able to pay all its short-term debts. +1
  • The TTM is 2.453. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.453TTM2.4530.000
TTM2.453YOY7.767-5.314
TTM2.4535Y9.340-6.887
5Y9.34010Y9.3400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4533.610-1.157
TTM2.4533.871-1.418
YOY7.7674.609+3.158
5Y9.3405.977+3.363
10Y9.3406.216+3.124
4.4.3.2. Quick Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 2.44 means the company can pay off $2.44 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 2.440. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.440. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.440TTM2.4400.000
TTM2.440YOY7.639-5.199
TTM2.4405Y9.183-6.743
5Y9.18310Y9.1830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4403.085-0.645
TTM2.4403.360-0.920
YOY7.6394.400+3.239
5Y9.1835.972+3.211
10Y9.1836.483+2.700
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Island Pharmaceuticals Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Island Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Island Pharmaceuticals Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.41 means that Island Pharmaceuticals Ltd assets are financed with 40.8% credit (debt) and the remaining percentage (100% - 40.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.408. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.408. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.408TTM0.4080.000
TTM0.408YOY0.129+0.279
TTM0.4085Y8.068-7.660
5Y8.06810Y8.0680.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4080.341+0.067
TTM0.4080.343+0.065
YOY0.1290.315-0.186
5Y8.0680.363+7.705
10Y8.0680.384+7.684
4.5.4.2. Debt to Equity Ratio

Measures if Island Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 68.8% means that company has $0.69 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Island Pharmaceuticals Ltd:

  • The MRQ is 0.688. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.688. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.688TTM0.6880.000
TTM0.688YOY0.148+0.541
TTM0.6885Y0.202+0.487
5Y0.20210Y0.2020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6880.386+0.302
TTM0.6880.429+0.259
YOY0.1480.391-0.243
5Y0.2020.450-0.248
10Y0.2020.495-0.293
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Island Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Island Pharmaceuticals Ltd to the Biotechnology industry mean.
  • A PE ratio of -6.12 means the investor is paying $-6.12 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -8.377. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.122. Based on the earnings, the company is expensive. -2
  • The TTM is -6.122. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.377MRQ-6.122-2.255
MRQ-6.122TTM-6.1220.000
TTM-6.122YOY-12.064+5.942
TTM-6.1225Y-7.248+1.126
5Y-7.24810Y-7.2480.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.377-2.247-6.130
MRQ-6.122-2.706-3.416
TTM-6.122-3.253-2.869
YOY-12.064-3.392-8.672
5Y-7.248-6.132-1.116
10Y-7.248-6.735-0.513
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is -7.581. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.540. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.540. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.581MRQ-5.540-2.041
MRQ-5.540TTM-5.5400.000
TTM-5.540YOY-12.606+7.065
TTM-5.5405Y-8.642+3.102
5Y-8.64210Y-8.6420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.581-3.026-4.555
MRQ-5.540-3.582-1.958
TTM-5.540-3.816-1.724
YOY-12.606-4.463-8.143
5Y-8.642-8.265-0.377
10Y-8.642-9.266+0.624
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Island Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 11.54 means the investor is paying $11.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Island Pharmaceuticals Ltd:

  • The EOD is 15.798. Based on the equity, the company is expensive. -2
  • The MRQ is 11.544. Based on the equity, the company is expensive. -2
  • The TTM is 11.544. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD15.798MRQ11.544+4.253
MRQ11.544TTM11.5440.000
TTM11.544YOY19.125-7.581
TTM11.5445Y8.314+3.231
5Y8.31410Y8.3140.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD15.7981.948+13.850
MRQ11.5442.223+9.321
TTM11.5442.427+9.117
YOY19.1252.469+16.656
5Y8.3143.767+4.547
10Y8.3144.507+3.807
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets2,564
Total Liabilities1,046
Total Stockholder Equity1,519
 As reported
Total Liabilities 1,046
Total Stockholder Equity+ 1,519
Total Assets = 2,564

Assets

Total Assets2,564
Total Current Assets2,564
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 1,660
Net Receivables 891
Other Current Assets 13
Total Current Assets  (as reported)2,564
Total Current Assets  (calculated)2,564
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,046
Long-term Liabilities0
Total Stockholder Equity1,519
Total Current Liabilities
Short-term Debt 422
Short Long Term Debt 422
Accounts payable 312
Other Current Liabilities 312
Total Current Liabilities  (as reported)1,046
Total Current Liabilities  (calculated)1,468
+/- 422
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock22,394
Retained Earnings -21,200
Accumulated Other Comprehensive Income 325
Total Stockholder Equity (as reported)1,519
Total Stockholder Equity (calculated)1,519
+/-0
Other
Capital Stock22,394
Cash and Short Term Investments 1,660
Common Stock Shares Outstanding 90,296
Current Deferred Revenue302
Liabilities and Stockholders Equity 2,564
Net Debt -1,238
Net Invested Capital 1,941
Net Working Capital 1,519
Short Long Term Debt Total 422



6.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
0
6,636
4,899
2,049
2,564
2,5642,0494,8996,6360
   > Total Current Assets 
0
6,636
4,899
2,049
2,564
2,5642,0494,8996,6360
       Cash And Cash Equivalents 
0
6,461
4,787
1,998
1,660
1,6601,9984,7876,4610
       Net Receivables 
0
59
21
17
891
8911721590
   > Long-term Assets 00000
       Other Assets 
0
314
0
0
0
0003140
> Total Liabilities 
1
237
581
264
1,046
1,0462645812371
   > Total Current Liabilities 
1
237
581
264
1,046
1,0462645812371
       Short-term Debt 
0
0
0
0
422
4220000
       Short Long Term Debt 
0
0
0
0
422
4220000
       Accounts payable 
134
82
241
113
312
31211324182134
       Other Current Liabilities 
1
155
340
151
312
3121513401551
   > Long-term Liabilities 00000
       Deferred Long Term Liability 
0
314
0
0
0
0003140
> Total Stockholder Equity
-1
6,399
4,318
1,785
1,519
1,5191,7854,3186,399-1
   Common Stock
0
19,826
19,901
19,901
22,394
22,39419,90119,90119,8260
   Retained Earnings -21,200-19,763-4,734-2,127-1
   Capital Surplus 00000
   Treasury Stock00000
   Other Stockholders Equity 
0
-11,299
-10,848
1,648
0
01,648-10,848-11,2990



6.3. Balance Sheets

Currency in AUD. All numbers in thousands.




6.4. Cash Flows

Currency in AUD. All numbers in thousands.




6.5. Income Statements

Currency in AUD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,252
Cost of Revenue-2,273
Gross Profit1,252-1,021
 
Operating Income (+$)
Gross Profit1,252
Operating Expense-4,125
Operating Income-2,874-2,874
 
Operating Expense (+$)
Research Development2,273
Selling General Administrative1,441
Selling And Marketing Expenses350
Operating Expense4,1254,063
 
Net Interest Income (+$)
Interest Income5
Interest Expense-46
Other Finance Cost-0
Net Interest Income-41
 
Pretax Income (+$)
Operating Income-2,874
Net Interest Income-41
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,864-2,883
EBIT - interestExpense = -2,920
-4,116
-2,818
Interest Expense46
Earnings Before Interest and Taxes (EBIT)-2,874-2,818
Earnings Before Interest and Taxes (EBITDA)-2,818
 
After tax Income (+$)
Income Before Tax-2,864
Tax Provision-0
Net Income From Continuing Ops-2,864-2,864
Net Income-2,864
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,125
Total Other Income/Expenses Net941
 

Technical Analysis of Island Pharmaceuticals Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Island Pharmaceuticals Ltd. The general trend of Island Pharmaceuticals Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Island Pharmaceuticals Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Island Pharmaceuticals Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.15 < 0.15 < 0.155.

The bearish price targets are: 0.11 > 0.11 > 0.1.

Tweet this
Island Pharmaceuticals Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Island Pharmaceuticals Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Island Pharmaceuticals Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) ChartIsland Pharmaceuticals Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Island Pharmaceuticals Ltd. The current adx is .

Island Pharmaceuticals Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Relative Strength Index (RSI) ChartIsland Pharmaceuticals Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Stochastic Oscillator ChartIsland Pharmaceuticals Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) ChartIsland Pharmaceuticals Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) ChartIsland Pharmaceuticals Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Williams %R ChartIsland Pharmaceuticals Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Average True Range (ATR) ChartIsland Pharmaceuticals Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily On-Balance Volume (OBV) ChartIsland Pharmaceuticals Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Island Pharmaceuticals Ltd.

Island Pharmaceuticals Ltd Daily Money Flow Index (MFI) ChartIsland Pharmaceuticals Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Island Pharmaceuticals Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-12-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-03SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-01-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-01-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Island Pharmaceuticals Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Island Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.130
Total0/1 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Island Pharmaceuticals Ltd with someone you think should read this too:
  • Are you bullish or bearish on Island Pharmaceuticals Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Island Pharmaceuticals Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Island Pharmaceuticals Ltd

I send you an email if I find something interesting about Island Pharmaceuticals Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Island Pharmaceuticals Ltd.

Receive notifications about Island Pharmaceuticals Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.